Epithelial-myoepithelial Carcinoma - 25 Studies Found Not yet recruiting : Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment : Clear Cell Renal Carcinoma : 2017-02-23 : Drug: Sunitinib Sunitinib 50 mg/d Active, not recruiting : Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer : Endometrial Clear Cell Adenocarcinoma Estrogen Receptor Negative Drug: Dasatinib Given PO Completed : Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer : Carcinoma Adenocarcinoma Renal Cell Drug: RAD001(everolimus) 10 mg Completed : Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer : Ovarian Clear Cell Cystadenocarcinoma Stage III Ovarian Cancer Drug: Carboplatin Given IV Completed : Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer : Endometrial Adenoacanthoma Endometrial Adenocarcinoma Endo : 2001-10-11 : Drug: thalidomide Given orally Recruiting : A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas : Ewing Sarcoma Gastrointestinal Tumor Germ Cell Tumor : 2012-06-19 : Drug: alemtuzumab Patients rec Completed : Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer : Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Radiation: intensity-modulated radiation therapy Completed : Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer : Endometrial Adenocarcinoma Endometrial Adenosquamous Cell Carcinoma Drug: temsirolimus Given IV Completed : High-dose Bevacizumab in Advanced Renal Carcinoma Patients : Renal Cancer Kidney Cancer : 2007-04-03 : Drug: Bevacizumab Bevacizumab Other Name: Avastin Terminated : A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers : Uterine Cancer : 2005-09-30 : Drug: Celecoxib <<< Previous | Next >>>